- Topic
61k Popularity
3k Popularity
8k Popularity
101 Popularity
6k Popularity
- Pin
- 🎉 The #CandyDrop Futures Challenge# is live — join now to share a 6 BTC prize pool!
📢 Post your futures trading experience on Gate Square with the event hashtag — $25 × 20 rewards are waiting!
🎁 $500 in futures trial vouchers up for grabs — 20 standout posts will win!
📅 Event Period: August 1, 2025, 15:00 – August 15, 2025, 19:00 (UTC+8)
👉 Event Link: https://www.gate.com/candy-drop/detail/BTC-98
Dare to trade. Dare to win. - 📢 Gate Square Exclusive: #WXTM Creative Contest# Is Now Live!
Celebrate CandyDrop Round 59 featuring MinoTari (WXTM) — compete for a 70,000 WXTM prize pool!
🎯 About MinoTari (WXTM)
Tari is a Rust-based blockchain protocol centered around digital assets.
It empowers creators to build new types of digital experiences and narratives.
With Tari, digitally scarce assets—like collectibles or in-game items—unlock new business opportunities for creators.
🎨 Event Period:
Aug 7, 2025, 09:00 – Aug 12, 2025, 16:00 (UTC)
📌 How to Participate:
Post original content on Gate Square related to WXTM or its - 🎉 Attention Alpha fans! Alpha’s latest TAG airdrop goes live today at 10 AM—first come, first served!
💰 Don’t forget to share your airdrop or points screenshot on Gate Square with the hashtag #ShowMyAlphaPoints# for a chance to win a share of the $200 token mystery box!
🥇 Top points winner: $100
✨ 5 outstanding posts: $20 each
📸 Pro tips:
Add a caption like “I earned ____ with Alpha. So worth it”
Share your points-earning tips or redemption experience for a better chance to win!
📅 Activity deadline: August 10, 18:00 UTC
Let’s go! See you tonight: https://www.gate.com/announcements/article - Hey fam—did you join yesterday’s [Show Your Alpha Points] event? Still not sure how to post your screenshot? No worries, here’s a super easy guide to help you win your share of the $200 mystery box prize!
📸 posting guide:
1️⃣ Open app and tap your [Avatar] on the homepage
2️⃣ Go to [Alpha Points] in the sidebar
3️⃣ You’ll see your latest points and airdrop status on this page!
👇 Step-by-step images attached—save it for later so you can post anytime!
🎁 Post your screenshot now with #ShowMyAlphaPoints# for a chance to win a share of $200 in prizes!
⚡ Airdrop reminder: Gate Alpha ES airdrop is - Gate Futures Trading Incentive Program is Live! Zero Barries to Share 50,000 ERA
Start trading and earn rewards — the more you trade, the more you earn!
New users enjoy a 20% bonus!
Join now:https://www.gate.com/campaigns/1692?pid=X&ch=NGhnNGTf
Event details: https://www.gate.com/announcements/article/46429
MEI Pharma’s Crypto Treasury Move: 930,000 Litecoin Tokens Acquired
MEI Pharma Inc. has become the first U.S.-listed public company to adopt litecoin ( LTC) as a primary reserve asset, deploying $100 million from a recent stock sale to acquire 929,548 tokens of the cryptocurrency.
Litecoin Creator Charlie Lee Joins MEI Pharma’s Board
The clinical-stage biopharmaceutical company (Nasdaq: MEIP) disclosed the LTC acquisition in an Aug. 5 regulatory filing. MEI Pharma purchased the litecoin ( LTC) tokens at an average price of $107.58 between July 30 and Aug. 4, 2025. The investment utilized all net proceeds from a private placement of common stock and warrants completed on July 17.
MEI Pharma’s litecoin holdings were valued at approximately $110.4 million as of Aug. 4. The company described the move as launching a “major institutional treasury strategy” built on “digital asset infrastructure and long-term capital innovation.” The plan was first revealed in mid-July.
The strategy was developed with crypto investment firm GSR and includes guidance from Litecoin creator Charlie Lee, who serves on MEI Pharma’s board. Lee stated the initiative recognizes LTC’s role “as both a reserve asset and an integral part of global financial systems.”
MEI Pharma cited Litecoin’s “proven reliability” with 13 years of operational uptime, low transaction fees, and “broad-based adoption” on platforms including Paypal, Venmo, and Bitpay as key reasons for the selection.
The San Diego-based company, founded in 2000, develops cancer therapies targeting hematologic malignancies and solid tumors. Its drug pipeline includes voruciclib, an oral cyclin-dependent kinase inhibitor. MEI Pharma reported having 28 employees as of July 2025.
The firm indicated plans to formally update its corporate identity in the coming weeks and may commence LTC mining activities. MEI Pharma emphasized it continues to assess preclinical activities for its oncology candidates alongside the LTC treasury strategy. Over the last month, MEIP shares have jumped 111% against the U.S. dollar.